Capital Flow Monitor · Sponsors · CIK 1728054
Cresilon, Inc.
122 18TH STREET, BROOKLYN, NY, 11215 · (347) 435-2226
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$29.0M
Sold
$29.0M
% sold
100.0%
Investors
217
Min investment
$10K
Exemption
506(c)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-06-26 | D/A ·current | 506(c) | $29.0M | $29.0M | 100.0% | 217 | EDGAR ↗ |
| 2026-04-29 | D | 506(b) | $25.0M | $5.0M | 20.0% | 21 | EDGAR ↗ |
| 2025-12-08 | D | 506(c) | $6.7M | $6.7M | 99.5% | 55 | EDGAR ↗ |
| 2025-09-05 | D | 506(b) | $34.8M | $17.2M | 49.4% | 95 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Joseph Landolina — Executive Officer / Director, Brooklyn, NY
- Isaac Miller — Director, Brooklyn, NY
-
Scott Levine — Executive Officer, Brooklyn, NY
5 other raises
- JBS Touring LLC $2.9M of $4.0M · 71.9%
- BVSC FIRST NATIONAL TOUR LLC $4.5M of $6.0M · 74.9%
- ABN Touring LLC $300K of $3.6M · 8.3%
- GG First National Tour LLC $7.2M of $7.9M · 90.8%
- BTJ Touring LLC $4.8M of $5.5M · 88.1%
Placement agents
- Paulson Investment Company, Llc · 0 RE raises
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.